ShareValue scores for EXOZ: Valuation 49, Quality 44, Growth 55, Health 48.
EXOZNASDAQ
eXoZymes, Inc.
$5.17
(-5.05%)
EXOZNASDAQ
eXoZymes, Inc.
$5.17(-5.05%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Moderate
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 17%
Rating
Trap Risk
Return
6% to 17%
Valuation
49
Fair Value
Price vs Value
Quality
44
Moderate
Business Strength
Growth
55
Moderate
Revenue & Earnings
Health
48
Moderate
Financial Stability
Momentum
22
Bearish
Price Trend
Company Details
About
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Market Cap$48M
P/E RatioN/A
Dividend YieldNone
Sector Rank#1380
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026